Matthew Stanton
Stock Analyst at Jefferies
(0.58)
# 4,132
Out of 5,102 analysts
7
Total ratings
50%
Success rate
-24.79%
Average return
Main Sectors:
Stocks Rated by Matthew Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AZTA Azenta | Upgrades: Buy | $30 → $38 | $37.50 | +1.33% | 2 | Oct 30, 2025 | |
| RGEN Repligen | Maintains: Hold | $145 → $135 | $161.66 | -16.49% | 1 | Sep 12, 2025 | |
| CYRX Cryoport | Downgrades: Hold | $20 → $8 | $9.64 | -17.01% | 2 | Aug 7, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $1.48 | +119.59% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $24.88 | -11.58% | 1 | Apr 4, 2024 |
Azenta
Oct 30, 2025
Upgrades: Buy
Price Target: $30 → $38
Current: $37.50
Upside: +1.33%
Repligen
Sep 12, 2025
Maintains: Hold
Price Target: $145 → $135
Current: $161.66
Upside: -16.49%
Cryoport
Aug 7, 2024
Downgrades: Hold
Price Target: $20 → $8
Current: $9.64
Upside: -17.01%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $1.48
Upside: +119.59%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $24.88
Upside: -11.58%